Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields

Glioblastoma multiforme (GBM) is the most common and malignant primary intracranial tumor, and has a median survival of only 10 to 14 months with only 3 to 5% of patients surviving more than three years. Recurrence (RGBM) is nearly universal, and further decreases the median survival to only five to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Rulseh, Aaron Michael, Keller, Jiří, Klener, Jan, Šroubek, Jan, Dbalý, Vladimír, Syrůček, Martin, Tovaryš, František, Vymazal, Josef
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514151/
https://ncbi.nlm.nih.gov/pubmed/23095807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-220
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki